Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PJP

Invesco Pharmaceuticals ETF

Mar 20 • 04:00PM ET

85.79

Dollar change +0.21
Percentage change 0.24	%

Financial • Exchange Traded Fund • USA • NYSE

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	8.93%	Shs Outstand		Perf Week	2.29%
Sponsor	Invesco	ETF Type		Tags	equity	Return% 3Y	4.72%	Total Holdings	32	Perf Month	-0.95%
Fund Family		Bond Type		Tags	pharmaceutical	Return% 5Y	10.13%	AUM	259.38M	Perf Quarter	2.34%
Index	Dynamic Pharmaceuticals Intellidex Indx	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	-2.84%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	8.88%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-0.99%	52W Range	75.33 - 89.87	Perf YTD	3.83%
Dividend TTM	0.80 (0.94%)	ESG Type		Tags	-	Flows% 3M	-5.06%	52W High	-4.54%	Beta	0.57
Dividend Ex-Date	Dec 23, 2024	Dividend Type		Sector/Theme		Flows% YTD	-5.93%	52W Low	13.89%	ATR (14)	0.96
Expense	0.56%	Structure Type		Region		Flows% 1Y		RSI (14)	51.53	Volatility	0.93% 1.04%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.65	Prev Close	85.58
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	7.22K	Price	85.79
SMA20	0.14%	SMA50	0.54%	SMA200	0.61%	Trades		Volume	4,727	Change	0.24%

Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
09:20AM	Invesco American Franchise Fund Q4 2024 Commentary (SeekingAlpha)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
08:45AM	Invesco Global Opportunities Fund Q4 2024 Commentary (SeekingAlpha)
07:00AM	Invesco Global Fund Q4 2024 Commentary (SeekingAlpha)
06:40AM	Loading…
06:40AM	Invesco Global Focus Fund Q4 2024 Commentary (SeekingAlpha)
06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
06:00AM	Invesco Multi-Asset Income Fund Q4 2024 Commentary (SeekingAlpha)
Mar-09-23 12:00PM	Biden targets crypto, real estate and oil industries, as he unveils his budget (MarketWatch)
Dec-28-22 03:30PM	Subversive Launches ETF to Focus on Mental Health (ETF.com)
Sep-20-22 03:13PM	Best Pharmaceutical ETFs for Q4 2022 (Investopedia)
Aug-02-21 06:18PM	Eli Lilly (LLY) Option Traders Prepped for Earnings Beat (Investopedia)
05:21PM	Amgen (AMGN) Option Traders Unenthusiastic Into Earnings (Investopedia)
Oct-30-20 04:14PM	Heres where Trump and Biden stand on COVID-19, other health-care issues (MarketWatch)
Aug-07-20 12:35PM	Trumps Buy American order on essential drugs looks toothless, analysts say (MarketWatch)
02:17PM	Loading…
Jul-31-20 02:17PM	Dont buy health-care stocks if Democrats sweep the November elections, these contrarian analysts say (MarketWatch)
Jul-28-20 12:00PM	Trumps meeting with pharma execs called off, as analysts say his moves on drug prices lack bite (MarketWatch)
Jul-24-20 04:10PM	Pharma stocks fall as Trump targets drug prices with executive orders (MarketWatch)
Jun-04-20 01:00PM	5 Sector ETFs Just Got Upgraded to Buy (Zacks)
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Feb-06-20 01:10PM	Trump rips very unfair impeachment effort as he celebrates acquittal at White House (MarketWatch)
Feb-05-20 05:03PM	Trump acquitted by Senate, ending historic impeachment trial (MarketWatch)
10:50AM	Trumps State of the Union speech: Investors in drug makers should be relieved, analyst says (MarketWatch)
Feb-04-20 02:51PM	Democratic caucus goers in Iowa focused most on health care, followed by climate change (MarketWatch)
Dec-20-19 08:10AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-12-19 02:34PM	Pelosis drug-pricing bill passes House, but pharma stocks are up as its unlikely to become law (MarketWatch)
Nov-08-19 08:00AM	Pharma Sector Tops in October: Best ETFs & Stocks (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
Oct-15-19 11:53AM	Johnson & Johnson Stock Has Good Numbers, But Bad Verdicts (InvestorPlace)
Sep-20-19 09:01AM	Pelosi says she hopes for Trumps support as she unveils plan to lower drug prices (MarketWatch)
04:43PM	Loading…
Sep-11-19 04:43PM	Potential Peanut Allergy Treatment Gives Pharma Company A Boost (ETF Trends)
Aug-27-19 10:05AM	Amgen to Buy Celgene's Otezla: 5 ETF Drugs (Zacks)
Aug-22-19 11:12AM	8 ETFs to Capture Opportunities in Healthcare Sector (ETF Trends)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
Jul-24-19 12:15PM	7 Bad ETFs That Just Arent Worth the Trouble This Year (InvestorPlace)
Jul-14-19 11:00AM	4 Hot Pharmaceutical ETFs (ETF Trends)
Jul-09-19 04:18PM	Drug Pricing War: Pharma, Biotech Stocks Score A Win Over Trump (Investor's Business Daily)
Jun-26-19 11:00AM	AbbVie to Buy Allergan: Prescribed ETFs (Zacks)
Jun-25-19 06:01PM	AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs (ETF Trends)
May-14-19 05:40PM	Legal Troubles Beset Pharmaceutical Sector ETFs (ETF Trends)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
Apr-09-19 02:14PM	4 ETFs to Consider with Big Pharma on the Senates Hot Seat (ETF Trends)
Mar-08-19 08:00AM	4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run (Zacks)
Mar-01-19 08:00AM	Why These Pharma ETFs Rallied on Thursday (Zacks)
Feb-28-19 04:43PM	Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results (ETF Trends)
Feb-21-19 10:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-29-19 09:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-07-19 09:27AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-04-19 10:01AM	Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus (Zacks)
Dec-14-18 09:28AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections (Zacks)
Oct-22-18 03:30PM	ETF Plays for a Divided Midterm Elections (ETF Trends)
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 (Investopedia)
Oct-09-18 11:39AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Sep-06-18 04:56PM	Pharmaceutical ETFs Could Maintain Their Momentum (ETF Trends)
Aug-12-18 04:56AM	Is Projprzem SAs (WSE:PJP) Balance Sheet Strong Enough To Weather A Storm? (Simply Wall St.)
Aug-02-18 10:47AM	5 Strong Healthcare ETFs to Buy (InvestorPlace)
Jul-03-18 03:19PM	July Could Be a Volatile Month for Pharma ETFs (ETF Trends)
Jun-11-18 03:23PM	Best Sector ETFs of Last Week (Zacks)
Jun-08-18 04:01PM	Play the Best Sector of Summer With These ETFs & Stocks (Zacks)
May-18-18 08:15AM	Who Are Projprzem SA.s (WSE:PJP) Major Shareholders? (Simply Wall St.)
May-11-18 04:18PM	6 Top Healthcare ETFs Rally as Trump Vows End to Global Freeloading (ETF Trends)
May-10-18 11:03AM	Does Projprzem SA.s (WSE:PJP) PE Ratio Signal A Buying Opportunity? (Simply Wall St.)
Apr-24-18 06:41AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Apr-20-18 12:38PM	Projprzem SA. (WSE:PJP) Delivered A Better ROE Than The Industry, Heres Why (Simply Wall St.)
Apr-13-18 09:15AM	Is Projprzem SA. (WSE:PJP) A Financially Sound Company? (Simply Wall St.)
Mar-24-18 10:47AM	How to Invest in Healthcare Stocks the Easy Way (Motley Fool)
Jan-23-18 01:12PM	Vermont Legalizes Recreational Marijuana on January 22, 2018 (Market Realist)
Jan-18-18 10:30AM	A Look into Amgens Collaborations in 2H17 (Market Realist)
Nov-22-17 10:31AM	Mercks Immunology and Oncology Drugs, Post-3Q17 (Market Realist)
Nov-13-17 03:03PM	What Led to the Rise in the US Trade Deficit in September? (Market Realist)
Oct-30-17 12:25PM	Top 3 Pharmaceutical ETFs of 2017 (Investopedia)
Sep-12-17 07:37AM	How Mercks Diabetes Portfolio Performed in 2Q17 (Market Realist)
Sep-08-17 07:37AM	Why Jazz Pharmaceuticals Vyxeos Could Boost Revenue Growth in 2018 (Market Realist)
Sep-05-17 09:06AM	Eli Lilly & Co.s Recent Developments after Its 2Q17 Earnings (Market Realist)
Sep-01-17 10:37AM	Performance of Eli Lillys Endocrine Franchise in 2Q17 (Market Realist)
10:36AM	How Pfizers Enbrel and Xeljanz Are Positioned after 2Q17 (Market Realist)
07:36AM	Ligand Pharmaceuticals Focuses on Increasing Returns for Shareholders (Market Realist)
07:36AM	A Post-2Q17 Look at Pfizers Internal Medicines (Market Realist)
Aug-31-17 01:39PM	Why $475,000 isn't actually that expensive for Novartis's new drug (Yahoo Finance)
01:05PM	Why a $475,000 drug price tag isn't expensive (Yahoo Finance Video)
07:36AM	Bristol-Myers Squibbs Immunoscience Products in 2Q17 (Market Realist)
Aug-30-17 02:27PM	Trump can lower U.S. drug prices by fixing NAFTA (Yahoo Finance)
Aug-28-17 09:06AM	A Look into Mercks Immunology and Oncology Portfolio (Market Realist)
Aug-23-17 11:54AM	What Jazz Pharmaceuticals Expects for Vyxeos (Market Realist)
Aug-22-17 09:07AM	How Allergans US Specialized Therapeutics Segment Performed in 2Q17 (Market Realist)
07:37AM	Behind Xyrems Solid Demand Trends in 2017 (Market Realist)
07:36AM	Eliquis and Sprycel Could Boost BMYs Revenue Growth in 2H17 (Market Realist)
Aug-17-17 07:36AM	How Amgens Nephrology Drugs Are Positioned after 2Q17? (Market Realist)
Aug-10-17 10:36AM	Celgenes Abraxane Continued Steady Growth in 2Q17 (Market Realist)
Aug-07-17 09:45AM	Q2 Earnings Fail to Impress Pharma ETF (Zacks)
Aug-04-17 01:57PM	Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does (InvestorPlace)
Aug-01-17 10:41AM	How Gilead Sciences HCV Franchise Is Positioned after 2Q17 (Market Realist)
09:09AM	Dupixent Could Substantially Drive Regenerons Growth (Market Realist)
Jul-31-17 04:36PM	Examining Bristol-Myers Squibbs Oncology Portfolios 2Q17 (Market Realist)
07:40AM	Eli Lilly in 2Q17: Humulin and Endocrine Products (Market Realist)
Jul-28-17 07:36AM	Behind Pfizers Legacy Established Products Performance in 2017 (Market Realist)
Jul-14-17 10:37AM	Behind Allergans Business Segments and Revenues (Market Realist)
Jul-10-17 03:10PM	What Lies Ahead for Pharma ETFs in Second Half 2017 (Zacks)

Invesco Dynamic Pharmaceuticals ETF seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

PJP

Invesco Pharmaceuticals ETF

Upgrade your FINVIZ experience